No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs77354949 |
chr1:63061814-63061815 |
Weak transcription Strong transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs573300763 |
chr1:63061825-63061826 |
Weak transcription Strong transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs35123493 |
chr1:63061840-63061841 |
Weak transcription Strong transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs72649570 |
chr1:63061844-63061845 |
Weak transcription Strong transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs149364366 |
chr1:63061850-63061851 |
Weak transcription Strong transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs547368927 |
chr1:63061869-63061870 |
Weak transcription Strong transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs141794880 |
chr1:63061885-63061886 |
Weak transcription Strong transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs11207997 |
chr1:63061906-63061907 |
Weak transcription Strong transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
9 |
rs181471655 |
chr1:63061924-63061925 |
Weak transcription Strong transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs150428533 |
chr1:63061940-63061941 |
Weak transcription Strong transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs564966056 |
chr1:63061960-63061961 |
Weak transcription Strong transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs563860868 |
chr1:63061971-63061972 |
Weak transcription Strong transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs186011618 |
chr1:63061984-63061985 |
Weak transcription Strong transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs72649572 |
chr1:63062018-63062019 |
Weak transcription Strong transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs530517180 |
chr1:63062036-63062037 |
Weak transcription Strong transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs546991207 |
chr1:63062075-63062076 |
Weak transcription Strong transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs565874988 |
chr1:63062131-63062132 |
Weak transcription Strong transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs568326118 |
chr1:63062202-63062203 |
Weak transcription Strong transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs191145608 |
chr1:63062216-63062217 |
Weak transcription Strong transcription Enhancers
|
CpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
20 |
rs554860249 |
chr1:63062242-63062243 |
Weak transcription Strong transcription Enhancers
|
CpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
21 |
rs532426120 |
chr1:63062258-63062259 |
Weak transcription Strong transcription Enhancers
|
CpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
22 |
rs537236179 |
chr1:63062281-63062282 |
Weak transcription Strong transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs558720437 |
chr1:63062305-63062306 |
Weak transcription Strong transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs576851908 |
chr1:63062307-63062308 |
Weak transcription Strong transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs540741675 |
chr1:63062314-63062315 |
Weak transcription Strong transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs552949139 |
chr1:63062320-63062321 |
Weak transcription Strong transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
27 |
rs138234803 |
chr1:63062376-63062377 |
Weak transcription Strong transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
28 |
rs551840638 |
chr1:63062401-63062402 |
Weak transcription Strong transcription Flanking Active TSS Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
29 |
rs536340521 |
chr1:63062439-63062440 |
Weak transcription Strong transcription Flanking Active TSS Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
30 |
rs181596788 |
chr1:63062490-63062491 |
Weak transcription Strong transcription Flanking Active TSS Enhancers
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
31 |
rs116514612 |
chr1:63062529-63062530 |
Weak transcription Strong transcription Flanking Active TSS Enhancers
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
32 |
rs531043366 |
chr1:63062533-63062534 |
Weak transcription Strong transcription Flanking Active TSS Enhancers
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
33 |
rs554752701 |
chr1:63062550-63062551 |
Weak transcription Strong transcription Flanking Active TSS Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
34 |
rs545963584 |
chr1:63062591-63062592 |
Weak transcription Strong transcription Flanking Active TSS Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
35 |
rs564309721 |
chr1:63062627-63062628 |
Weak transcription Strong transcription Flanking Active TSS Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
36 |
rs569711057 |
chr1:63062635-63062636 |
Weak transcription Strong transcription Flanking Active TSS Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
37 |
rs528598005 |
chr1:63062637-63062638 |
Weak transcription Strong transcription Flanking Active TSS Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
38 |
rs546735134 |
chr1:63062645-63062646 |
Weak transcription Strong transcription Flanking Active TSS Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
39 |
rs568447559 |
chr1:63062667-63062668 |
Weak transcription Strong transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs529271399 |
chr1:63062724-63062725 |
Weak transcription Strong transcription Flanking Active TSS Enhancers
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
41 |
rs185773146 |
chr1:63062737-63062738 |
Weak transcription Strong transcription Flanking Active TSS Enhancers
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
42 |
rs191086880 |
chr1:63062811-63062812 |
Weak transcription Strong transcription Flanking Active TSS Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
43 |
rs149558895 |
chr1:63062822-63062823 |
Weak transcription Strong transcription Flanking Active TSS Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
44 |
rs528161173 |
chr1:63062859-63062860 |
Weak transcription Strong transcription Flanking Active TSS Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
45 |
rs183279674 |
chr1:63062946-63062947 |
Weak transcription Strong transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs187806040 |
chr1:63062971-63062972 |
Weak transcription Strong transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs191171206 |
chr1:63062986-63062987 |
Weak transcription Strong transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs546741644 |
chr1:63063031-63063032 |
Weak transcription Strong transcription Active TSS Enhancers Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
49 |
rs570519859 |
chr1:63063099-63063100 |
Weak transcription Strong transcription Active TSS Enhancers Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
50 |
rs568241193 |
chr1:63063163-63063164 |
Weak transcription Strong transcription Active TSS Enhancers Flanking Active TSS
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|